Hepatitis B and hepatitis C viruses: A review of viral genomes, viral induced host immune responses, genotypic distributions and worldwide epidemiology

Asian Pacific Journal of Tropical Disease

Volumn 4, Issue 2, 2014, Pages 88-96

  Saeed, Umar ^a   Waheed, Yasir ^a   Ashraf, Muhammad ^a  

^a NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

Author keywords

Epidemiology of HBV and HCV; Genome analysis of HBV and HCV; Genotypic distribution of HBV and HCV; HCV; Hepatitis B virus

Indexed keywords

GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 5B; PEGINTERFERON ALPHA; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ARTICLE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DEVELOPING COUNTRY; ENDEMIC DISEASE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTERNAL RIBOSOME ENTRY SITE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SEROPREVALENCE; VIRAL TROPISM; VIREMIA; VIRUS CARRIER; VIRUS GENOME;

EID: 84886695152     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(14)60322-4     Document Type: Article

References (70)

1. Scarborough A Hepatitus B. 2010. [Online] [Accessed on 27 July, 2013]. http://www.austincc.edu/microbio/2704z/hbv.htm.
2. Yates S, Penning M, Goudsmit J, Frantzen I, Weijer BV, Strijp DV, Gemen BV Quantitative detection of hepatitis B Virus DNA by real-time nucleic acid sequence-based amplification with molecular beacon detection. J Clin Microbiol 2011, 39(10):36-56.
3. Yen TSB Hepadnaviral X protein: Review of recent progress. J Biomed Sci 1996, 3:20-30.
4. Hruska JF, Robinson WS The proteins of hepatitis B Dane particle cores. J Med Virol 1977, 1(2):119-131.
5. World Health Organization Hepatitis B. 2008. [Online] [Accessed on 27 July, 2013]. http://www.who.int/mediacentre/factsheets/fs204/en/.
6. Everson GT, Weinberg H Living with hepatitis B: A survivor's guide 2002, Hatherleigh Press, US.
7. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244(4902):359-362.
8. Conca P, Tarantino G Hepatitis C virus lymphotropism and peculiar immunological phenotype: Effects on natural history and antiviral therapy. World J Gastroenterol 2009, 15(19):2305-2308.
9. Penin F, Dubuisson J Structural biology of hepatitis C virus. Hepatology 2004, 39(1):5-19.
10. Appel N, Pietschmann T, Bartenschlager R Mutational analysis of hepatitis C virus nonstructural protein 5A: Potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain. J Virol 2005, 79(5):3187-3194.
11. Seeger C, Mason WS Hepatitis B virus biology. Microbiol Mol Biol Rev 2000, 64:51-68.
12. Summers J, Mason WS Replication of the genome of a hepatitis B like virus by reverse transcription of an RNA intermediate. Cell 1982, 29:403-415.
13. Tong S, Kim KH, Chante C, Wands J, Jisu L Hepatitis B virus e antigen variants. Int J Med Sci 2005, 2(1):2-7.
14. Chen MT, Billaud JN, Sallberg M, Guidotti LG, Chisari FV, Jones J, et al. A function of HBV precore protein is to regulate immune response to core antigen. Proc Natl Acad Sci USA 2004, 101(41):14913-14918.
15. Summers J, Connel A Genome of Hepatitis B virus restriction enzyme cleavage abd structure of DNA extracted from Dane particles. Proc Natl Acad Sci USA 1975, 72:4597-4601.
16. Tiollais P, Pourcel C, Dejean A The hepatitis B virus. Nature 1985, 317:489-495.
17. Cattaneo R, Will H, Schaller H Hepatitis B virus transcription in the infected liver. EMBO J 1984, 3(9):2191-2196.
18. Enders GH, Ganem D, Varmus H Mapping the major transcripts of ground squirrel hepatitis virus: the presumptive template for reverse transcriptase is terminally redundant. Cell 1985, 42(1):297-308.
19. Center for Disease Control and Prevention Hepatitis. 2010. [Online] [Accessed on 27 July, 2013]. http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/hep_b/slide_4.htm.
20. Sprengers D Immune response and immunomodulation in chronic hepatitis B virus infection. [Online] [Accessed on 27 July, 2013]. http://repub.eur.nl/res/pub/8063/061101_Sprengers,%20Dave.pdf.
21. Butel JS Papovaviruses. Medical microbiology 2005, Mosby, Philadelphia, Chapter 66. 5th ed. S. Baron, T. Albrecht, G. Castro, R.B. Couch, C.P. Davis (Eds.).
22. Lok AS, McMahon BJ Chronic hepatitis B: Update 2009. AASLD practice guideline update. [Online] [Accessed on 27 July, 2013]. http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf.
23. Kim JW, Ye Q, Forgues M, Chen Y, Budhu A, Sime J, et al. Cancer associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology 2004, 39:518-527.
24. Samuel LK, Ronald C, Stanley E, James D, Caroline B, Cleveland, et al. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP); 1991. [Online] [Accessed on 27 July, 2013]. http://www.cdc.gov/mmwr/preview/mmwrhtml/00033405.htm.
25. Moradpour D, Blum HE A primer on the molecular virology of hepatitis C. Liver Int 2004, 24(6):519-525.
26. Ahmad A, Alvarez F Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. J Leukoc Biol 2004, 76(4):743-759.
27. Shoukry NH, Cawthon AG, Walker CM Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol 2004, 58:391-424.
28. Mann EA, Stanford S, Sherman KE Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kB activation. Vir Res 2006, 121:51-57.
29. Kieft JS, Zhou K, Grech A, Jubin R, Doudna JA Crystal structure of an RNA tertiary domain essential to HCV IRES-mediated translation initiation. Nat Struct Mol Biol 2002, 5:370-374.
30. Guo JT, Sohn JA, Zhu Q, Seeger C Mechanism of the interferon alpha response against hepatitis C virus replicons. Virology 2004, 325:71-81.
31. Trujillo-Murillo KC, Garza-Rodeiguex ML, Martinez-Rodiguex HG, Barrera-Saladana HA, Bosques-Padilla F, Ramos-Jimenez J, et al. Experimental models for hepatitis C virus (HCV) new opportunities for combating hepatitis C. Ann Hepatol 2004, 3(2):54-62.
32. Mercer DF, Schiller DE, Elliott JF, Douglas DN, Hao C, Rinfret A, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001, 7(8):927-933.
33. Sun DX, Liu L, Heinz B, Kolykhalov A, Lamar J, Johnson RB, et al. P4 cap modified tetrapeptidyl alpha-ketoamides as potent HCV NS3 protease inhibitors. Bioorg Med Chem Lett 2004, 14:4333-4338.
34. American Liver Foundation Liver awareness month. New York: American Liver Foundation. [Online] [Accessed on 27 July, 2013]. http://www.liverfoundation.org.
35. Carroll SS, Ludmerer S, Handt L, Koeplinger K, Zhang NR, Graham D, et al. Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees. Antimicrob Agents Chemother 2009, 53(3):926-934.
36. Center for Disease Control and Prevention Hepatitis C FAQs for the public; 2012. [Online] [Accessed on 27 July, 2013]. http://www.cdc.gov/hepatitis/c/cfaq.htm.
37. Kowdley KV Hematologic side effects of interferon and ribavirin therapy. J Clin Gastroenterol 2005, 39:3-8.
38. Kramvis A, Kew M, François G Hepatitis B virus genotypes. Vaccine 2005, 23(19):2409-2423.
39. Olinger CM, Jutavijittum P, Hubschen JM, Yousukh A, Sumountry B, Thammavong T, et al. Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis 2008, 14(11):1777-1780.
40. Ali M, Idrees M, Ali L, Hussain A, Rehman I, Saleem S, et al. Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes. Virol J 2011, 8:102.
41. Awan Z, Idrees M, Amin I, Butt S, Afzal S, Akbar H, et al. Pattern and molecular epidemiology of hepatitis B virus genotypes circulating in Pakistan. Infect Genet Evol 2010, 10:1242-1246.
42. Cavinta L, Cao G, Schaefer S A new isolate of hepatitis B virus from the Philippines possibly representing a new subgenotype C6. J Med Virol 2009, 81(6):983-987.
43. Mahtab MA, Rahman S, Khan M, Karim F Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 2008, 7(5):457-464.
44. Palumbo E Hepatitis B genotypes and response to antiviral therapy: a review. Am J Ther 2007, 14(3):306-309.
45. Kurbanov F, Tanaka Y, Kramvis A, Simmonds P, Mizokami M When should "I" consider a new hepatitis B virus genotype. J Virol 2008, 82(16):8241-8242.
46. World Health Organization Hepatitis C. 2003 2003, World Health Organization, Geneva, [Online], [Assessed on 16 July, 2013]. http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/index2.html.
47. Walewski JL, Gutierrez JA, Branch-Elliman W, Stump DD, Keller TR, Rodriguez A, et al. Mutation master: Profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions. RNA 2002, 8:557-571.
48. Alestig E Geographic and genetic diversity of hepatitis B [Accessed on 27 July, 2013]. https://gupea.ub.gu.se/handle/2077/22932.
49. Idrees M, Riazuddin S Frequency distribution of hepatitis C virus genotypes in different gepgraphical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008, 8:69.
50. Narahari S, Juwle A, Basak S, Saranath D Prevalence and geographic distribution of Hepatitis C virus genotypes in Indian patient cohort. Infect Genet Evol 2009, 9(4):636-645.
51. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unied system of nomenclature of hepatitis C virus genotypes. Hepatology 2005, 42(4):962-973.
52. Viral Hepatitis Prevention Report The hepatitis C virus. 2002. [Online] [Accessed on 27 July, 2013]. http://www.vhpb.org/files/html/Meetings_and_publications/VHPB_Meetings/geneva2002.htm.
53. Hou JL, Liu ZH, Gu F Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005, 2(1):50-57.
54. Colin WS, Simard EP, Finelli L, Fiore AE, Bell BP Hepatitis B virus infection. epidemiology and vaccination. Oxford J Epidemol Rev 2006, 28:112-125.
55. Alter MJ Epidemiology and prevention of hepatitis B. Semin Liver Dis 2003, 23(1):39-46.
56. Margolis HS, Alter MJ, Hadler SC Hepatitis B: Evolving epidemiology and implications for control. Semin Liver Dis 1991, 11:84-92.
57. Toukan A Strategy for the control of hepatitis B virus infection in the Middle East and North Africa. Vaccine 1990, 8:S117-S121.
58. Kurien T, Thyagarajan SP, Jeyaseelan L Community prevalence of hepatitis B infection and modes of transmission in Tamil Nadu, India. Indian J Med Res 2005, 121:670-675.
59. Iashina TL, Favorov MO, Shakhgil'dian IV The prevalence of the markers of viral hepatitis B and delta among the population in regions differing in the level of morbidity. Vopr Virusol 1992, 37:194-196.
60. Erden S, Buyukozturk S, Calangu S A study of serological markers of hepatitis B and C viruses in Istanbul, Turkey. Med Princ Pract 2003, 12:184-188.
61. Da-Villa G, Sepe A Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness. Vaccine 1999, 17:1734-1738.
62. McQuillan GM, Townsend TR, Fields HA, Carroll M, Leahy M, Polk BF Seroepidemiology of hepatitis B virus infection in the United States. Am J Med 1989, 87(3):S5-S10.
63. World Health Organization The world health report 2006-working together for health 2006, World Health Organization, Geneva, [Online], [Accessed on 27 July, 2013]. http://www.who.int/whr/2006/en/.
64. Shepard CW, Finelli L, Alter MJ Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005, 5:558-567.
65. Wikipedia List of countries by population. 2011. [Online] [Accessed on 27 July, 2013]. http://en.wikipedia.org/wiki/List_of_countries_by_population.
66. Hepatitis C articles (HCV). [Online] [Accessed on 27 July, 2013]. http://www.natap.org/2011/HCV/080211_01.htm.
67. Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003, 37:802-809.
68. Sulaiman HA, Julitasari, Sie A, Rustam M, Melani W, Corwin A, et al. Prevalence of hepatitis B and C viruses in healthy Indonesian blood donors. Trans R Soc Trop Med Hyg 1995, 89:167-170.
69. Brandao AB, Costa FS Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study. BMC Gastroenterol 2002, 2:18.
70. Khattak MF, Salamat N, Bhatti FA, Qureshi TZ Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc 2002, 52:398-402.